Eli Book Value Per Share from 2010 to 2025

LLY Stock

USD 817.49 9.27 1.12%

Eli Lilly Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Eli Lilly and according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

15.90083094

Current Value

16.7

Quarterly Volatility

4.32120692

Credit Downgrade

Yuan Drop

Covid

Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 966.6 M, Interest Expense of 635.7 M or Total Revenue of 47.3 B, as well as many indicators such as Price To Sales Ratio of 16.15, Dividend Yield of 0.0064 or PTB Ratio of 50.8. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.

Check out the analysis of Eli Lilly Correlation against competitors.

Latest Eli Lilly's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Eli Lilly and over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Eli Lilly's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 15.81 X

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Eli Book Value Per Share Regression Statistics

	Arithmetic Mean	11.44
	Geometric Mean	10.15
	Coefficient Of Variation	37.76
	Mean Deviation	3.17
	Median	12.15
	Standard Deviation	4.32
	Sample Variance	18.67
	Range	14.5319
	R-Value	0.19
	Mean Square Error	19.30
	R-Squared	0.04
	Significance	0.49
	Slope	0.17
	Total Sum of Squares	280.09

Eli Book Value Per Share History

	2025	16.7
	2024	15.9
	2023	12.08
	2022	11.95
	2021	10.09
	2020	6.42
	2019	2.9

Other Fundumenentals of Eli Lilly

Tangible Book Value Per Share

Eli Lilly Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.16	0.06	0.08	0.95	0.97	0.02	0.65	0.84	0.98	-0.33	-0.73	-0.73	0.92	0.54	0.82	0.65	0.86	-0.47	0.63	0.78	-0.14	0.79	-0.44	0.66	-0.35
Total Stockholder Equity	0.16		-0.32	0.97	-0.01	-0.07	0.08	-0.14	0.11	0.11	0.69	0.47	0.47	-0.17	-0.07	0.35	0.01	-0.01	0.67	-0.44	-0.23	0.7	-0.01	0.17	0.31	0.16
Net Debt	0.06	-0.32		-0.32	0.29	0.17	0.78	0.57	-0.08	0.05	-0.32	-0.36	-0.36	0.06	0.37	0.28	0.44	0.2	-0.54	0.51	0.36	-0.24	0.19	-0.36	-0.19	-0.63
Retained Earnings	0.08	0.97	-0.32		-0.12	-0.14	0.13	-0.18	0.01	0.01	0.77	0.57	0.57	-0.26	-0.02	0.28	-0.03	-0.15	0.68	-0.5	-0.31	0.78	-0.11	0.31	0.15	0.28
Net Receivables	0.95	-0.01	0.29	-0.12		0.97	0.14	0.75	0.79	0.95	-0.51	-0.84	-0.84	0.92	0.51	0.81	0.69	0.91	-0.6	0.76	0.85	-0.29	0.81	-0.58	0.64	-0.53
Total Liab	0.97	-0.07	0.17	-0.14	0.97		0.03	0.71	0.81	0.96	-0.5	-0.85	-0.85	0.97	0.57	0.78	0.69	0.87	-0.65	0.77	0.87	-0.3	0.8	-0.51	0.6	-0.4
Total Current Assets	0.02	0.08	0.78	0.13	0.14	0.03		0.25	-0.2	-0.1	0.05	0.03	0.03	-0.16	0.29	0.35	0.21	-0.11	-0.19	0.23	0.16	0.13	0.06	0.15	-0.28	-0.2
Intangible Assets	0.65	-0.14	0.57	-0.18	0.75	0.71	0.25		0.36	0.67	-0.4	-0.74	-0.74	0.67	0.53	0.64	0.78	0.75	-0.72	0.75	0.71	-0.17	0.43	-0.71	0.25	-0.64
Short Term Debt	0.84	0.11	-0.08	0.01	0.79	0.81	-0.2	0.36		0.87	-0.26	-0.57	-0.57	0.79	0.29	0.56	0.52	0.79	-0.25	0.39	0.55	-0.12	0.92	-0.41	0.78	-0.42
Accounts Payable	0.98	0.11	0.05	0.01	0.95	0.96	-0.1	0.67	0.87		-0.38	-0.76	-0.76	0.94	0.48	0.76	0.67	0.92	-0.47	0.62	0.76	-0.19	0.82	-0.57	0.72	-0.45
Short Term Investments	-0.33	0.69	-0.32	0.77	-0.51	-0.5	0.05	-0.4	-0.26	-0.38		0.78	0.78	-0.59	-0.26	-0.2	-0.27	-0.42	0.75	-0.75	-0.68	0.88	-0.29	0.46	-0.2	0.27
Capital Stock	-0.73	0.47	-0.36	0.57	-0.84	-0.85	0.03	-0.74	-0.57	-0.76	0.78		1.0	-0.88	-0.49	-0.5	-0.58	-0.81	0.85	-0.86	-0.85	0.66	-0.61	0.64	-0.36	0.52
Common Stock	-0.73	0.47	-0.36	0.57	-0.84	-0.85	0.03	-0.74	-0.57	-0.76	0.78	1.0		-0.88	-0.49	-0.5	-0.58	-0.81	0.85	-0.86	-0.85	0.66	-0.61	0.64	-0.36	0.52
Long Term Debt	0.92	-0.17	0.06	-0.26	0.92	0.97	-0.16	0.67	0.79	0.94	-0.59	-0.88	-0.88		0.52	0.68	0.65	0.87	-0.68	0.78	0.86	-0.41	0.75	-0.54	0.62	-0.35
Treasury Stock	0.54	-0.07	0.37	-0.02	0.51	0.57	0.29	0.53	0.29	0.48	-0.26	-0.49	-0.49	0.52		0.56	0.62	0.42	-0.54	0.57	0.59	-0.2	0.39	-0.17	0.14	-0.18
Property Plant Equipment	0.82	0.35	0.28	0.28	0.81	0.78	0.35	0.64	0.56	0.76	-0.2	-0.5	-0.5	0.68	0.56		0.74	0.68	-0.4	0.66	0.8	0.0	0.59	-0.4	0.6	-0.29
Good Will	0.65	0.01	0.44	-0.03	0.69	0.69	0.21	0.78	0.52	0.67	-0.27	-0.58	-0.58	0.65	0.62	0.74		0.7	-0.62	0.74	0.75	-0.15	0.64	-0.55	0.52	-0.5
Current Deferred Revenue	0.86	-0.01	0.2	-0.15	0.91	0.87	-0.11	0.75	0.79	0.92	-0.42	-0.81	-0.81	0.87	0.42	0.68	0.7		-0.51	0.66	0.73	-0.24	0.77	-0.75	0.69	-0.67
Net Tangible Assets	-0.47	0.67	-0.54	0.68	-0.6	-0.65	-0.19	-0.72	-0.25	-0.47	0.75	0.85	0.85	-0.68	-0.54	-0.4	-0.62	-0.51		-0.92	-0.82	0.66	-0.39	0.48	-0.06	0.37
Long Term Debt Total	0.63	-0.44	0.51	-0.5	0.76	0.77	0.23	0.75	0.39	0.62	-0.75	-0.86	-0.86	0.78	0.57	0.66	0.74	0.66	-0.92		0.95	-0.59	0.52	-0.54	0.36	-0.38
Capital Surpluse	0.78	-0.23	0.36	-0.31	0.85	0.87	0.16	0.71	0.55	0.76	-0.68	-0.85	-0.85	0.86	0.59	0.8	0.75	0.73	-0.82	0.95		-0.54	0.61	-0.54	0.51	-0.33
Long Term Investments	-0.14	0.7	-0.24	0.78	-0.29	-0.3	0.13	-0.17	-0.12	-0.19	0.88	0.66	0.66	-0.41	-0.2	0.0	-0.15	-0.24	0.66	-0.59	-0.54		-0.18	0.31	-0.04	0.16
Short Long Term Debt	0.79	-0.01	0.19	-0.11	0.81	0.8	0.06	0.43	0.92	0.82	-0.29	-0.61	-0.61	0.75	0.39	0.59	0.64	0.77	-0.39	0.52	0.61	-0.18		-0.4	0.7	-0.55
Cash And Equivalents	-0.44	0.17	-0.36	0.31	-0.58	-0.51	0.15	-0.71	-0.41	-0.57	0.46	0.64	0.64	-0.54	-0.17	-0.4	-0.55	-0.75	0.48	-0.54	-0.54	0.31	-0.4		-0.47	0.79
Net Invested Capital	0.66	0.31	-0.19	0.15	0.64	0.6	-0.28	0.25	0.78	0.72	-0.2	-0.36	-0.36	0.62	0.14	0.6	0.52	0.69	-0.06	0.36	0.51	-0.04	0.7	-0.47		-0.28
Net Working Capital	-0.35	0.16	-0.63	0.28	-0.53	-0.4	-0.2	-0.64	-0.42	-0.45	0.27	0.52	0.52	-0.35	-0.18	-0.29	-0.5	-0.67	0.37	-0.38	-0.33	0.16	-0.55	0.79	-0.28

Click cells to compare fundamentals

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	15.90	16.70
Tangible Book Value Per Share	2.60	4.64

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC